JAN 05, 2017 1:37 PM PST

Study: Chemo Brain Persists for Months After Treatment

WRITTEN BY: Xuan Pham

Chemotherapy is an aggressive attack on the cancer, and on the body. For some women treated with chemo for breast cancer, the effects of chemo seem to reach as far as the brain. The effect, dubbed “chemo brain,” is sparsely known but not deemed as a pervasive side effect of chemotherapy. But now, a new study sheds light on when chemo brain happens and the big impact this effect actually has on the lives of breast cancer patients.

Going through chemotherapy takes a toll on the body and the mind. But for years, doctors and patients focused more on the drugs’ effects on the body. Lapses in mental acuity and memory blurs after chemotherapy were perceived as anecdotal evidence of chemo’s effects in the brain. But it was only recently that researchers really took notice of these reports and linked chemo brain as a side effect of cancer treatment.

But just how pervasive this side effect really is was unknown. To understand this problem, researchers from the University of Rochester Medical Center in New York collected data from 581 breast cancer patients and 364 healthy women. The large sample size makes this one of the largest studies to date to investigate chemo brain.

Led by Michelle Janelsins, the team assessed the women’s cognitive status before, during, and after chemotherapy period. Of note, typical reports of chemo brain include mental fogginess, the inability to concentrate, and general difficulties with cognitive tasks that didn't use to be problematic.

To assess the women’s cognitive changes, the team used the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), a well-known questionnaire that takes into account the patient’s perspective as well as the perspective of others around them.

The findings confirm that chemo brain is indeed quite real. A whopping 45.2 percent of breast cancer showed a decrease in FACT-Cog scores, while only 10.4 percent of healthy women reported any decline. More surprising, the effects seemed to persist even as long as 6 months after the treatment ended. At 6 months post-chemo, 18.4 percent of women with breast cancer still reported “clinically meaningful perceived decline” as compared to only 11.5 percent of control participants.

"Our study, from one of the largest nationwide studies to date, shows that cancer-related cognitive problems are a substantial and pervasive issue for many women with breast cancer,” said Janelsins.

Factors that exacerbate cognitive decline after chemo seem to include symptoms of anxiety and depression before chemotherapy. In addition, cognitive decline seemed to also be correlated with age and race.

“We are currently assessing these data in the context of objective cognitive measures and to understand the role of possible biologic mechanisms that may confer risk to cognitive problems in patients,” said Janelsins. Future studies may also point out if the link between chemotherapy and cognitive decline also includes male cancer patients.

Additional source: University of Rochester Medical Center press release, MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 08, 2021
Cancer
Activating p53 May Boost Efficacy of Cancer Immunotherapy
JUL 08, 2021
Activating p53 May Boost Efficacy of Cancer Immunotherapy
Pharmacological activation of the p53 protein in cancer cells leads to an anti-tumor immune response in lab tests. These ...
JUL 16, 2021
Cancer
Exercise Slows Growth of Bowel Cancer Cells
JUL 16, 2021
Exercise Slows Growth of Bowel Cancer Cells
Exercise releases molecules into the bloodstream that reduce the growth of bowel cancer cells, say researchers from the ...
JUL 16, 2021
Drug Discovery & Development
Machine Learning Ranks Cancer Drugs by Efficacy
JUL 16, 2021
Machine Learning Ranks Cancer Drugs by Efficacy
A machine learning algorithm developed by researchers at the Queen Mary University of London in the UK can rank cancer d ...
AUG 18, 2021
Cell & Molecular Biology
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
AUG 18, 2021
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
For many years, researchers have studied how an enzyme called APOBEC3 can help protect the body from pathogenic viruses, ...
OCT 04, 2021
Cancer
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
OCT 04, 2021
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
Reports indicate that caffeine consumption in the United States is greatest in adults aged 50 – 64.  Coincide ...
OCT 26, 2021
Immunology
Two Different Arms, Twice the Cancer-Killing Potential?
OCT 26, 2021
Two Different Arms, Twice the Cancer-Killing Potential?
Our immune system has developed an arsenal of sophisticated molecular weapons to defend us against the continuous barrag ...
Loading Comments...